Search

Displaying results 8251 - 8260 of 10000 in total
  1. Drug

    Abagovomab

    go.drugbank.com/drugs/DB16077
    Investigational

    Abagovomab is under investigation in clinical trial NCT00418574 (Efficacy Multicentre Trial of Immunotherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients).

    Categories: Amino Acids, Peptides, and Proteins
  2. Drug

    Selenomethionine Se-75

    go.drugbank.com/drugs/DB09400
    Approved

    Categories: Amino Acids, Peptides, and Proteins
  3. Drug

    Plutavimab

    go.drugbank.com/drugs/DB18856
    Investigational

    Plutavimab is under investigation in clinical trial NCT04900428 (Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (UK)).

    Categories: Amino Acids, Peptides, and Proteins
  4. Drug

    IMMU-114

    go.drugbank.com/drugs/DB18458
    Investigational

    IMMU-114 is antibody-drug conjugate consisting of humanized anti-HLA-DR IgG4 monoclonal antibody specific for alpha-chain linked to SN-38 via a CL2A linker.

    Categories: Amino Acids, Peptides, and Proteins
  5. Drug

    Monophosphothiamine

    go.drugbank.com/drugs/DB16023
    Experimental

    Mixtures: NEO CROMATON BICOMPLESSO
  6. Drug

    Drisapersen

    go.drugbank.com/drugs/DB13688
    ApprovedWithdrawn

    Categories: Nucleic Acids, Nucleotides, and Nucleosides
  7. Drug

    Corynebacterium diphtheriae CRM197 protein

    go.drugbank.com/drugs/DB16712
    ApprovedInvestigational

    Categories: Amino Acids, Peptides, and Proteins
  8. Drug

    SIG-207

    go.drugbank.com/drugs/DB18547
    Experimental

    SIG-207 is a Cultured human retinal pigment epithelial cells (ARPE-19) genetically modified with a non-viral vector to express Human alpha-galactosidase A (alpha-Gal A), encapsulated within two-layer modified

  9. Drug

    Teceleukin

    go.drugbank.com/drugs/DB15389
    Investigational

    Teceleukin is under investigation in clinical trial NCT03610490 (Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Osteosarcoma, or Pancreatic Ductal Adenocarcinoma).

    Categories: Amino Acids, Peptides, and Proteins, Intercellular Signaling Peptides and Proteins
  10. Drug

    Tigatuzumab

    go.drugbank.com/drugs/DB15101
    Investigational

    Tigatuzumab is under investigation in clinical trial NCT00991796 (CS-1008 With Carboplatin/Paclitaxel in Chemotherapy naïve Subjects With Metastatic or Unresectable Non-small Cell Lung Cancer (NSCLC)).

    Categories: Amino Acids, Peptides, and Proteins